Practice Management News

PHILADELPHIA — A novel risk score accurately predicted interstitial lung disease in patients with systemic sclerosis at the time of diagnosis, which may reduce unnecessary CT screening, according to data presented at ACR Convergence 2022.

More than 3 million middle and high school students reported continuous tobacco use in 2022, according to findings published in MMWR.

Boston-area school districts that lifted mask mandates earlier this year experienced nearly 45 more cases of COVID-19 per 1,000 students and staff than school districts that kept their mandates in place, a study found.

Social determinants of health, including lower socioeconomic status and a higher proportion of racially minoritized groups, correlated with higher likelihood of COVID-19-related death, according to a recent study in Clinical Infectious Diseases.

So, you’ve reached consensus with your partners that it’s time to sell the practice. You’ve done your research on potential platforms/buyers, and you’ve started to engage advisers. What’s next? Time to look inward.

Respiratory tract and total body burden of SARS-CoV-2 infection could predict how long patients will take to recover and provide insight into long COVID, according to a recent study published in Clinical Infectious Diseases.

Novavax on Monday said that its omicron subvariant vaccine candidate and original COVID-19 vaccine both performed well in a phase 3 trial testing three vaccines as a second booster dose.

Daily e-cigarette use among teens “seemed to accelerate” after 2017, according to a new study in JAMA Network Open.

Pfizer and BioNTech said Friday that their bivalent COVID-19 booster, which targets the original strain of SARS-CoV-2 and the omicron BA.4 and BA.5 sublineages, elicits stronger immune responses than their original vaccine.

At a Medical Devices Advisory Committee meeting held Nov. 1, panelists recommended improvements to the FDA regarding pulse oximeters and their accuracy among patients with darker skin pigmentation.